Geode Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $395K | Sell |
|
|||||
|
2024
Q2 | $605K | Sell |
|
|||||
|
2024
Q1 | $1.21M | Buy |
|
|||||
|
2023
Q4 | $1.18M | Buy |
|
|||||
|
2023
Q3 | $3.47M | Buy |
|
|||||
|
2023
Q2 | $4.18M | Buy |
|
|||||
|
2023
Q1 | $5.76M | Buy |
|
|||||
|
2022
Q4 | $5.85M | Buy |
|
|||||
|
2022
Q3 | $5.19M | Buy |
|
|||||
|
2022
Q2 | $8.43M | Sell |
|
|||||
|
2022
Q1 | $10.2M | Buy |
|
|||||
|
2021
Q4 | $10.4M | Sell |
|
|||||
|
2021
Q3 | $11.9M | Buy |
|
|||||
|
2021
Q2 | $8.62M | Buy |
|
|||||
|
2021
Q1 | $7.77M | Buy |
|
|||||
|
2020
Q4 | $7.31M | Sell |
|
|||||
|
2020
Q3 | $6.79M | Sell |
|
|||||
|
2020
Q2 | $7.97M | Buy |
|
|||||
|
2020
Q1 | $7.11M | Sell |
|
|||||
|
2019
Q4 | $9.68M | Buy |
|
|||||
|
2019
Q3 | $8.99M | Buy |
|
|||||
|
2019
Q2 | $8.73M | Buy |
|
|||||
|
2019
Q1 | $7.64M | Buy |
|
|||||
|
2018
Q4 | $5.32M | Buy |
|
|||||
|
2018
Q3 | $8.27M | Buy |
|
|||||
|
2018
Q2 | $7.72M | Buy |
|
|||||
|
2018
Q1 | $4.18M | Buy |
|
|||||
|
2017
Q4 | $4.15M | Sell |
|
|||||
|
2017
Q3 | $5.58M | Buy |
|
|||||
|
2017
Q2 | $7.08M | Sell |
|
|||||
|
2017
Q1 | $7.5M | Buy |
|
|||||
|
2016
Q4 | $5.61M | Buy |
|
|||||
|
2016
Q3 | $4.79M | Buy |
|
|||||
|
2016
Q2 | $2.61M | Sell |
|
|||||
|
2016
Q1 | $2.77K | Sell |
|
|||||
|
2015
Q4 | $6.2M | Buy |
|
|||||
|
2015
Q3 | $5.17M | Buy |
|
|||||
|
2015
Q2 | $5.28M | Buy |
|
|||||
|
2015
Q1 | $2.01M | Buy |
|
|||||
|
2014
Q4 | $465K | Buy |
|
|||||
|
2014
Q3 | $378K | Buy |
|
|||||
|
2014
Q2 | $173K | Sell |
|
|||||
|
2014
Q1 | $175K | Buy |
|